Deutsche Bank (ETR:DBKGn) initiated coverage on shares of Biohaven Pharmaceutical (TADAWUL:2070) Holding (NYSE:BHVN) with a Buy rating and a price target of $65.00. The firm's analysts cited the ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement saying his office and 37 other states, including Puerto Rico, had settled ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

With yet another quarter where Pfizer handily beat consensus earnings expectations, it’s even more clear that CEO Albert Bourla is already well on his way toward getting Pfizer back on track—as we ...

Florida's Medicaid Fraud Control Unit secured the win through a multistate action. Pharmaceutical giant Pfizer will be paying more than $2.3 million on behalf of its wholly owned subsidiary ...

30, 2022. Pfizer announced its plans to acquire Biohaven Pharmaceuticals in May 2022. The pharmaceutical juggernaut’s largest manufacturing facility is in Portage, Michigan, which employs ...

The $59,746,277 settlement resolves a federal court case that Connecticut and 37 other states and Puerto Rico had joined against Biohaven Pharmaceutical Holding Company Ltd., a Pfizer-owned local ...

A coalition consisting of the U.S. Department of Justice, 37 states, and Puerto Rico, filed suit against Biohaven Pharmaceutical Holding Company, a subsidiary owned by Pfizer.